Last reviewed · How we verify
Aripriprazole
At a glance
| Generic name | Aripriprazole |
|---|---|
| Sponsor | Northwell Health |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group
- Treatment and Outcome of Early Onset Bipolar Disorder (PHASE4)
- Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aripriprazole CI brief — competitive landscape report
- Aripriprazole updates RSS · CI watch RSS
- Northwell Health portfolio CI